News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
19,943 Results
Type
Article (2078)
Company Profile (13)
Press Release (17852)
Multimedia
Podcasts (5)
Webinars (1)
Section
Business (5926)
Career Advice (62)
Deals (789)
Drug Development (3277)
Employer Resources (3)
FDA (592)
Job Trends (760)
News (10276)
Policy (732)
Tag
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Biotech Beach Digital (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (283)
Adcomms (2)
Allergies (1)
Alliances (1735)
ALS (11)
Alzheimer's disease (297)
Antibody-drug conjugate (ADC) (5)
Approvals (590)
Artificial intelligence (17)
Autoimmune disease (1)
Automation (2)
Bankruptcy (5)
Best Places to Work (739)
Biosimilars (2)
Biotechnology (11)
Brain cancer (4)
Cancer (38)
Cardiovascular disease (3)
Career advice (49)
Career pathing (2)
CAR-T (4)
Cell therapy (11)
Cervical cancer (1)
Clinical research (2575)
Collaboration (54)
Compensation (12)
Complete response letters (1)
COVID-19 (44)
C-suite (20)
Data (111)
Depression (29)
Diabetes (3)
Diagnostics (69)
Diversity, equity & inclusion (1)
Drug discovery (4)
Duchenne muscular dystrophy (7)
Earnings (1387)
Editorial (5)
Employer branding (1)
Employer resources (3)
Events (2829)
Executive appointments (53)
FDA (640)
Featured Employer (3)
Funding (44)
Gene therapy (11)
GLP-1 (25)
Government (77)
Guidances (4)
Healthcare (573)
Huntington's disease (4)
IgA nephropathy (1)
Immunology and inflammation (6)
Indications (1)
Infectious disease (44)
Inflammatory bowel disease (10)
Inflation Reduction Act (1)
Intellectual property (3)
Interviews (12)
IPO (301)
IRA (1)
Job creations (92)
Job search strategy (45)
Layoffs (23)
Legal (93)
Liver cancer (1)
Lung cancer (4)
Lymphoma (3)
Management (1)
Manufacturing (7)
Medical device (257)
Medtech (258)
Mergers & acquisitions (520)
Metabolic disorders (9)
Multiple sclerosis (20)
Neurodegenerative disease (22)
Neuropsychiatric disorders (13)
Neuroscience (480)
NextGen: Class of 2025 (231)
Non-profit (218)
Northern California (98)
Now hiring (3)
Obesity (6)
Opinion (8)
Ovarian cancer (3)
Pain (9)
Pancreatic cancer (2)
Parkinson's disease (41)
Patents (10)
Patient recruitment (3)
People (2566)
Pharmaceutical (2)
Phase I (583)
Phase II (955)
Phase III (1179)
Pipeline (54)
Policy (4)
Postmarket research (133)
Preclinical (381)
Prostate cancer (1)
Psychedelics (8)
Radiopharmaceuticals (6)
Rare diseases (17)
Real estate (150)
Recruiting (1)
Regulatory (634)
Research institute (237)
Resumes & cover letters (9)
Rett syndrome (2)
Schizophrenia (39)
Series A (11)
Series B (4)
Sickle cell disease (2)
Southern California (175)
Special edition (3)
Spinal muscular atrophy (31)
Sponsored (1)
Startups (144)
Supply chain (1)
Tariffs (2)
The Weekly (5)
United States (1080)
Vaccines (8)
Venture capitalists (5)
Weight loss (3)
Date
Today (7)
Last 7 days (36)
Last 30 days (117)
Last 365 days (1523)
2025 (505)
2024 (1573)
2023 (1665)
2022 (1853)
2021 (2030)
2020 (1585)
2019 (1357)
2018 (1037)
2017 (1050)
2016 (1058)
2015 (1216)
2014 (870)
2013 (642)
2012 (614)
2011 (532)
2010 (457)
Location
Africa (17)
Arizona (5)
Arkansas (1)
Asia (1369)
Australia (179)
California (313)
Canada (107)
China (28)
Colorado (7)
Connecticut (27)
Delaware (1)
Europe (3256)
Florida (58)
Georgia (2)
Idaho (2)
Illinois (71)
Indiana (18)
Japan (9)
Kentucky (1)
Maine (4)
Maryland (35)
Massachusetts (249)
Michigan (2)
Minnesota (11)
Montana (1)
Nebraska (1)
Nevada (2)
New Hampshire (3)
New Jersey (60)
New Mexico (1)
New York (114)
North Carolina (13)
Northern California (98)
Ohio (8)
Pennsylvania (65)
Rhode Island (1)
South America (18)
South Carolina (1)
Southern California (175)
Tennessee (3)
Texas (13)
Utah (8)
Virginia (2)
Washington D.C. (4)
Washington State (15)
Wisconsin (2)
19,943 Results for "amygdala neurosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
ABMRF Invests in Amygdala Neurosciences to Develop ANS-858 for Alcohol Use Disorder
Amygdala Neurosciences announced that the Company has closed a new round of equity financing led by ABMRF, the Alcohol Beverage Medicines Research Foundation to fund the Company’s IND-stage activities for ANS-858.
May 14, 2024
·
4 min read
Biotech Bay
Amygdala Neurosciences Awarded $2.0 million NIH Grant to Conduct IND Enabling Studies
Amygdala Neurosciences has been awarded a $2.0 million NIH grant to support the project titled “Investigational New Drug -enabling and Early-Stage Development of Selective, Reversible, Orally Bioavailable ALDH2 inhibitor ANS-00858 to Treat Alcohol Use Disorder.”
August 1, 2023
·
3 min read
Neurodegenerative disease
Denali Goes All In on Neuroscience’s Thorniest Hurdle: Crossing the Blood-Brain Barrier
After some high-profile crashes, the one-time biotech darling is inching toward success with its Hunter syndrome treatment, which today began a rolling BLA for accelerated approval.
April 2, 2025
·
5 min read
·
Dan Samorodnitsky
Pipeline
AstraZeneca Abandons Neuroscience, Prioritizes Weight Loss, Immunology
Following the recent discontinuations of assets in Alzheimer’s and migraine, AstraZeneca is stepping away from neuro altogether.
April 29, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Alto Neuroscience to Participate in the JonesResearch Virtual CNS Day
April 22, 2025
·
1 min read
Press Releases
Dalen Meeter Joins Aspen Neuroscience as Chief Financial Officer
May 1, 2025
·
2 min read
Press Releases
Precision Neuroscience Adds Med-Tech Veterans To Accelerate Commercialization
May 1, 2025
·
3 min read
Press Releases
Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience
February 19, 2025
·
4 min read
Press Releases
Unlearn and Trace Neuroscience Partner to Optimize ALS Clinical Trial
April 1, 2025
·
3 min read
Press Releases
Precision Neuroscience Receives FDA Clearance for High-Resolution Cortical Electrode Array
April 17, 2025
·
3 min read
1 of 1,995
Next
